Conditional <i>Cdk5rap2</i> KO mouse and novel <i>mCdk5rap2</i> splice variants. by Nadine Kraemer (790327)

“…(D) Identification of a novel <i>mCdk5rap2</i> splice variant (<i>mCdk5rap2-V1</i>) through gel electrophoresis and sequencing of PCR products from exon 2 to exon 7 of WT and hom KO cDNA. …”

<i>Donson</i> expression in the developing telencephalon. by Sathish Venkataramanappa (10331993)

<i>Donson</i> expression in the embryonic telencephalon. by Sathish Venkataramanappa (10331993)

Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin‑4 Using Quantitative SILAC-Based Proteomics by Malwina Michalak (505581)

“…The strongest induction was found for CALB2 (calretinin; ∼24-fold), TGM2 (protein-glutamine γ-glutamyltransferase 2; ∼11-fold), S100A3 (∼10-fold), and GSN (gelsolin; 9.5-fold), and the most pronounced decreases were seen for CDKN2A (tumor suppressor ARF; ∼6-fold), EPCAM (epithelial cell adhesion molecule; ∼6-fold), UBE2C (ubiquitin-conjugating enzyme E2 C; ∼5-fold), KIF2C (kinesin-like protein KIF2C; 5-fold), and LMNB1 (lamin-B1; ∼5-fold). …”

Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin‑4 Using Quantitative SILAC-Based Proteomics by Malwina Michalak (505581)

“…The strongest induction was found for CALB2 (calretinin; ∼24-fold), TGM2 (protein-glutamine γ-glutamyltransferase 2; ∼11-fold), S100A3 (∼10-fold), and GSN (gelsolin; 9.5-fold), and the most pronounced decreases were seen for CDKN2A (tumor suppressor ARF; ∼6-fold), EPCAM (epithelial cell adhesion molecule; ∼6-fold), UBE2C (ubiquitin-conjugating enzyme E2 C; ∼5-fold), KIF2C (kinesin-like protein KIF2C; 5-fold), and LMNB1 (lamin-B1; ∼5-fold). …”

<i>Emx1</i>-cKO mice lack the neocortex. by Sathish Venkataramanappa (10331993)

Aspirin-Triggered Resolvin D1 Attenuate IL-1β-induced Intercellular Adhesion Molecule-1 Expression. by Ruan Cox Jr. (789575)

Fourteen days after tMCAo surgery mice with RNS60 treatment show a decrease in microglial activation Iba1 (+) in the CA3 region of the ipsilateral hippocampus. by Gloria Patricia Baena-Caldas (17721328)

Pathological changes in the kidneys of mice in various groups were assessed using HE staining and transmission electron microscopy. by Lu Lin (201289)

<i>yhp1-13A yox1-9A</i> cells are sensitive to cell wall stressors. by Michelle M. Conti (13514386)

(a) Longitudinal section of the biventricular heart geometry; (b) Purkinje structure with terminal Purkinje muscle junctions. by Aditya V. S. Ponnaluri (3164673)

Positive genetic interactions between <i>yhp1-13A yox1-9A</i> and condensin. by Michelle M. Conti (13514386)

Ferroelectricity and a 1/3-Magnetization Plateau in the Polar Magnet LiFeV₂O₇ with Fe³⁺ Ions in a Twisted Diamond Chain by Ravi Shankar P N (9740817)

“…LiFeV₂O₇ crystallizes in a polar monoclinic <i>Cc</i> structure, where Fe³⁺ (<i>S</i> = 5/2) ions form diamond chains along the [101] direction, each surrounded by four neighboring chains. …”

Relationships between the unconfined compressive strength and destructive strains εf and E₅₀: (a) Relationship between the destructive strain εf and peak strength q<sub>... by Xiaoyan Ding (291429)

Regional FC within STM network for CN (A), FBSS (B) and the difference (C). by Peter A. Pahapill (8468607)

The number of mGE-derived cIN is reduced in <i>Nkx2</i>.<i>1</i>-cKO mice. by Sathish Venkataramanappa (10331993)

<i>Donson</i> deletion in the <i>Emx1</i> lineage induces apoptosis in the early pallium. by Sathish Venkataramanappa (10331993)

Proportion of weekly visitation (response variable) for each managerial jurisdiction – federal, state, and local – over a 22-week visitation season from 2017 to 2021. by Kira Minehart (21029571)

Data Sheet 1_Impact of the SARS-COV-2 pandemic on access to health services in Angola: a focus on diagnosis and treatment services for tuberculosis.docx by Susanna Caminada (16789893)

“…</p>Results<p>There was a significant decline in access to TB services during the pandemic, with a substantial decrease in reported cases (−15.5% in 2020; −18.3% in 2021) and treatment rate (from 86% in 2019 to 68% in 2020), an increase in multidrug-resistant-TB (from 0.2% in 2018 to 2.1% in 2022) and TB/HIV co-infections (from 6% in 2018 to 8.8% in 2021). …”

A representative set of trials. by Giulio Contemori (7019876)